Andere Sprachen Nang Kuang Pharmaceutical Co., Ltd.

Aktien

1752

TW0001752004

1752

Schlusskurs Taiwan S.E. Andere Börsenplätze 00:00:00 26.04.2024			% 5 Tage	% 1. Jan.
44,55 ^TWD	-0,11 %		+1,02 %	-16,42 %

26.03.	Nang Kuang Pharmaceutical Co. Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
12.03.	Nang Kuang Pharmaceutical Co., Ltd. kündigt Änderungen beim leitenden Innenrevisor an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26.03.
Nang Kuang Pharmaceutical Co., Ltd. Announces Changes in Chief Internal Auditor	12.03.
Nang Kuang Pharmaceutical Co., Ltd. Appoints Pen-Sung Chen as Corporate Governance Officer	08.03.
Nang Kuang Pharmaceutical Co., Ltd. Announces Resignation of Wen-Yung Tsai as Spokesperson, Financial Officer, Accounting Officer and Corporate Governance Officer	07.02.
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02.11.
Nang Kuang Pharmaceutical Co., Ltd.(TWSE:1752) added to S&P Global BMI Index	18.09.23
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10.08.23
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12.05.23
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	06.03.23
Nang Kuang Pharmaceutical Co., Ltd. Appoints Wen-Yung Tsai as Corporate Governance Officer	04.11.22
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	04.11.22
Nang Kuang Pharmaceutical : Announcement of the consolidated financial report for the 2nd quarter of 2022 approved by the board of directors	03.08.22
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	03.08.22
Nang Kuang Pharmaceutical : has received final U.S.FDA approval for its ANDA.	26.05.22
Nang Kuang Pharmaceutical Co., Ltd. Receives Final U.S. FDA Approval for Its ANDA	26.05.22
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	04.05.22
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	02.03.22
Nang Kuang Pharmaceutical Co., Ltd.(TWSE:1752) added to Taiwan TAIEX Index	17.02.22
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	05.11.21
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended 31 March 2021	13.05.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Nang Kuang Pharmaceutical Co., Ltd.

Aktien

1752

TW0001752004

1752

Andere Sprachen

Filter